Lithium recovery from brine using a λ-MnO2/activated carbon hybrid supercapacitor system.

Lithium is one of the most important elements in various fields including energy storage, medicine manufacturing and the glass industry, and demands for lithium are constantly increasing these days. The lime soda evaporation process using brine lake water is the major extraction method for lithium, but this process is not only inefficient and time-consuming but also causes a few environmental problems. Electrochemical recovery processes of lithium ions have been proposed recently, but the better idea for the silver negative electrodes used in these systems is required to reduce its cost or increase long term stability. Here, we report an electrochemical lithium recovery method based on a λ-MnO2/activated carbon hybrid supercapacitor system. In this system, lithium ions and counter anions are effectively captured at each electrode with low energy consumption in a salt solution containing various cationic species or simulated Salar de Atacama brine lake water in Chile. Furthermore, we designed this system as a flow process for practical applications. By experimental analyses, we confirmed that this system has high selectivity and long-term stability, with its performance being retained even after repetitive captures and releases of lithium ions.

Recovery of valuable elements from spent Li-batteries.

This work examines two recycling processes for spent Li/MnO(2) and Li-ion batteries. The anode, cathode and electrolyte (LiPF(6)) were submitted to one of the following procedures: (a) calcination at 500 degrees C (5h) followed by solvent extraction to recover lithium salts (fluoride, phosphate) in good yield (90 wt%). The residual solid was treated with H(2)SO(4) containing H(2)O(2) and on evaporation gave high purity grade cobalt or manganese sulfate; (b) fusion with KHSO(4) (500 degrees C, 5h). The resulting aqueous solution was added dropwise to a solution of NaOH, giving cobalt or manganese as impure precipitate. Addition of KF precipitated high purity grade LiF in moderate yield (50 wt%). The final aqueous solution on treatment with calcium sulfate precipitated the corresponding phosphate and fluoride salts.

Extraction of lithium from spodumene by bioleaching.

The recovery of lithium from spodumene (6.9% Li2O) by bioleaching was investigated. This process was carried out using heterotrophic micro-organisms previously isolated from the mineral. Penicillium purpurogenum, Aspergillus niger and Rhodotorula rubra were assayed separately. Two different media were used for bioleaching; one of them (M2 medium) was highly limited in Mg2+, Fe2+ and K+. The assays were carried out in 500 ml Erlenmeyer flasks with 1 g of ground mineral at 50-80 mesh and 150 ml of leaching medium. Lithium extracted and accumulated in biomass during 30 d of bioleaching with P. purpurogenum was 6.35 mg % dry weight (d.w.) in M1 medium and 10.8 mg % d.w. in M2 medium, while in the leach liquor, Li concentration was 1.06 ppm (M1 medium) and 1.26 ppm (M2 medium). Results of leaching on day 30 with R. rubra were 5.87 mg % d.w. and 16.7 mg % d.w. of lithium accumulated in biomass in M1 medium and M2 medium, respectively. In leach liquor, lithium was 0.5 ppm (M1 medium) and 1.53 ppm (M2 medium). Aspergillus niger was able to accumulate 1.60 mg % d.w. (M1 medium) and 5.1 mg % d.w. of lithium (M2 medium) in biomass. Lithium in leach liquor was 0.37 ppm (M1 medium) and 0.75 ppm (M2 medium). Chemical analysis of the leach liquor showed gluconic and citric acids. It was possible to detect capsular exopolymers in the yeast. These metabolic products seem to be related to leaching but a more important factor for enhancing this process may be microbial adaptation to a low nutrient environment.

Monitoreo terapéutico del litio

El litio es un fármaco de elección para el tratamiento de la manía y para el mantenimiento a largo plazo en la prevención de las crisis maníacas o depresivas del trastorno bipolar. Un conocimiento profundo del litio es necesario para alcanzar una utilización más segura y efectiva. Es un fármaco que debe ser utilizado con mucha precaución debido a su estrecha ventana terapéutica y la letalidad de la toxicidad relacionada con el mismo. Los pacientes deben ser evaluados clínica y paraclínicamente antes de iniciar la terapia con litio. Las interacciones farmacológicas deben ser tenidas presentes y se recomienda que la litemia, función tiroidea y función renal deben ser evaluadas mediante el laboratorio en asocio con un seguimiento clínico estricto. Las muestras de sangre para efectuar el monitoreo deben ser tomadas luego de cuatro días de estar tomando una dosis constante, doce horas después de la dosis de la noche y justo antes de tomar la de la mañana.